BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30300202)

  • 41. 18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
    Florimonte L; Orunesu E; Castellani M; Longari V; Cortelezzi A
    Clin Nucl Med; 2016 May; 41(5):394-6. PubMed ID: 26825195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.
    Wang L; Dong P; Hu W; Tian B
    Medicine (Baltimore); 2020 Jan; 99(5):e18980. PubMed ID: 32000430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
    Rensi M; Ferretti G; Di Gregorio F; Evangelista L
    Clin Nucl Med; 2019 Feb; 44(2):e116-e117. PubMed ID: 30516662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
    Parekh A; Hagan I; Capaldi L; Lyburn I
    Clin Nucl Med; 2017 Sep; 42(9):721-722. PubMed ID: 28682845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of
    de-Bonilla-Damiá Á; Fernández-López R; Capote-Huelva FJ; de la Cruz-Vicente F; Egea-Guerrero JJ; Borrego-Dorado I
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):298-303. PubMed ID: 28438519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply.
    Goineau A; Supiot S
    Clin Nucl Med; 2016 Sep; 41(9):746-7. PubMed ID: 27088390
    [No Abstract]   [Full Text] [Related]  

  • 49. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
    Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
    Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravascular Large B-Cell Lymphoma Identified by PET/CT.
    Liu W; Liu M; Guan M; Huang J; Xie P
    Clin Nucl Med; 2023 Jun; 48(6):528-529. PubMed ID: 37019128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
    Mylam KJ; Nielsen AL; Pedersen LM; Hutchings M
    PET Clin; 2014 Oct; 9(4):443-55, vi. PubMed ID: 26050946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unexpected Symmetrical Uptake of 18 F-FDG of Distal Peripheral Bones in a Patient With Diffuse Large B-Cell Lymphoma.
    Güneren C; Şahin K; Sönmezoğlu K
    Clin Nucl Med; 2024 Jan; 49(1):e14-e16. PubMed ID: 37976524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
    Kitajima K; Yamamoto S; Odawara S; Kobayashi K; Fujiwara M; Kamikonya N; Fukushima K; Nakanishi Y; Hashimoto T; Yamada Y; Suzuki T; Kanematsu A; Nojima M; Yamakado K
    Acta Med Okayama; 2018 Jun; 72(3):289-296. PubMed ID: 29926007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How we read FCH-PET/CT for prostate cancer.
    Beauregard JM; Beaulieu A
    Cancer Imaging; 2016 Dec; 16(1):41. PubMed ID: 27923396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F-FDG PET/CT demonstrated symmetric FDG uptake in internal capsule in a diffuse large B cell lymphoma patient with false interpretation on multiparametric brain MRI.
    Liu J; Wang W; Yang J
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2923-2924. PubMed ID: 32130449
    [No Abstract]   [Full Text] [Related]  

  • 56. Virchow Node From Prostate Carcinoma by 18F-Choline PET/CT.
    de la Riva-Pérez PA; García-Gómez FJ; Buján-Lloret C; Calvo-Morón MC; Castro-Montaño J
    Clin Nucl Med; 2018 Apr; 43(4):271-272. PubMed ID: 29356745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
    Mapelli P; Incerti E; Ceci F; Castellucci P; Fanti S; Picchio M
    J Nucl Med; 2016 Oct; 57(Suppl 3):43S-48S. PubMed ID: 27694171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging.
    Nitsch S; Hakenberg OW; Heuschkel M; Dräger D; Hildebrandt G; Krause BJ; Schwarzenböck SM
    J Nucl Med; 2016 Oct; 57(Suppl 3):38S-42S. PubMed ID: 27694169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.